A pharmacological assessment of agonists and modulators at α4β2γ2 and α4β2δ GABAA receptors: The challenge in comparing apples with oranges

Pharmacological Research

Volumn 111, Issue , 2016, Pages 563-576

  Ahring, Philip K ^a,b   Bang, Line H ^c   Jensen, Marianne L ^c   Strøbæk, Dorte ^b   Hartiadi, Leonny Y ^a   Chebib, Mary ^a   Absalom, Nathan ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Saniona AB   (Denmark)

^c NEUROSEARCH A S   (Denmark)

Author keywords

Alfaxalone; Allopregnanolone; DS2; GABAA receptor; Muscimol; THIP

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA4; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA4BETA2DELTA; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA4BETA2GAMMA2; ALFAXALONE; ETOMIDATE; GABOXADOL; MUSCIMOL; PENTOBARBITAL; TAURINE; TETRAHYDRODEOXYCORTICOSTERONE; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; COMPLEMENTARY DNA; STEROID;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; DRUG POTENCY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOPUS LAEVIS; ANIMAL; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; PHYSIOLOGY; PROTEIN SUBUNIT;

ANESTHETICS; ANIMALS; DNA, COMPLEMENTARY; FEMALE; GABA-A RECEPTOR AGONISTS; HUMANS; OOCYTES; PROTEIN SUBUNITS; RECEPTORS, GABA-A; STEROIDS; XENOPUS LAEVIS;

EID: 84979609885     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.05.014     Document Type: Article

References (37)

1. [1] Nusser, Z., Sieghart, W., Somogyi, P., Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J. Neurosci. 18:5 (1998), 1693–1703.
2. [2] Wei, W., et al. Perisynaptic localization of delta subunit-containing GABA(A) receptors and their activation by GABA spillover in the mouse dentate gyrus. J. Neurosci. 23:33 (2003), 10650–10661.
3. [3] Cope, D.W., Hughes, S.W., Crunelli, V., GABAA receptor-mediated tonic inhibition in thalamic neurons. J. Neurosci. 25:50 (2005), 11553–11563.
4. [4] Herd, M.B., et al. Extrasynaptic GABA(A) receptors couple presynaptic activity to postsynaptic inhibition in the somatosensory thalamus. J. Neurosci. 33:37 (2013), 14850–14868.
5. [5] Wafford, K.A., et al. Novel compounds selectively enhance delta subunit containing GABA A receptors and increase tonic currents in thalamus. Neuropharmacology 56:1 (2009), 182–189.
6. [6] Jensen, M.L., et al. A study of subunit selectivity: mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABA(A) receptors. Br. J. Pharmacol. 168:5 (2013), 1118–1132.
7. [7] Shu, H.J., et al. Characteristics of concatemeric GABA(A) receptors containing alpha4/delta subunits expressed in Xenopus oocytes. Br. J. Pharmacol. 165:7 (2012), 2228–2243.
8. [8] Shu, H.J., et al. Slow actions of neuroactive steroids at GABAA receptors. J. Neurosci. 24:30 (2004), 6667–6675.
9. [9] Hosie, A.M., et al. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444:7118 (2006), 486–489.
10. [10] Farrant, M., Nusser, Z., Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat. Rev. Neurosci. 6:3 (2005), 215–229.
11. [11] Mortensen, M., et al. Distinct activities of GABA agonists at synaptic- and extrasynaptic-type GABAA receptors. J. Physiol. 588:Pt. 8 (2010), 1251–1268.
12. [12] Eaton, M.M., et al. gamma-aminobutyric acid type A alpha4: beta2, and delta subunits assemble to produce more than one functionally distinct receptor type. Mol. Pharmacol. 86:6 (2014), 647–656.
13. [13] Brickley, S.G., Mody, I., Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease. Neuron 73:1 (2012), 23–34.
14. [14] Belelli, D., et al. Extrasynaptic GABAA receptors of thalamocortical neurons: a molecular target for hypnotics. J. Neurosci. 25:50 (2005), 11513–11520.
15. [15] Herd, M.B., et al. The expression of GABAA beta subunit isoforms in synaptic and extrasynaptic receptor populations of mouse dentate gyrus granule cells. J. Physiol. 586:4 (2008), 989–1004.
16. [16] Jia, F., Pignataro, L., Harrison, N.L., GABAA receptors in the thalamus: alpha4 subunit expression and alcohol sensitivity. Alcohol 41:3 (2007), 177–185.
17. [17] Brown, N., et al. Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors. Br. J. Pharmacol. 136:7 (2002), 965–974.
18. [18] Mirza, N.R., et al. NS11394 3′-5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl-biphenyl-2-carbonitrile, a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy. J. Pharmacol. Exp. Ther. 327:3 (2008), 954–968.
19. [19] Mortensen, M., Patel, B., Smart, T.G., GABA potency at GABA(A) receptors found in synaptic and extrasynaptic zones. Front. Cell. Neurosci., 6, 2011 p. 1.
20. [20] Storustovu, S.I., Ebert, B., Pharmacological characterization of agonists at delta-containing GABAA receptors: functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2. J. Pharmacol. Exp. Ther. 316:3 (2006), 1351–1359.
21. [21] Meera, P., et al. Etomidate: propofol and the neurosteroid THDOC increase the GABA efficacy of recombinant alpha4beta3delta and alpha4beta3 GABA A receptors expressed in HEK cells. Neuropharmacology 56:1 (2009), 155–160.
22. [22] Karim, N., et al. Potency of GABA at human recombinant GABA(A) receptors expressed in Xenopus oocytes: a mini review. Amino Acids 44:4 (2013), 1139–1149.
23. [23] Bowen, M.T., et al. Oxytocin prevents ethanol actions at delta subunit-containing GABAA receptors and attenuates ethanol-induced motor impairment in rats. Proc. Natl. Acad. Sci. U. S. A. 112:10 (2015), 3104–3109.
24. [24] Akk, G., Bracamontes, J., Steinbach, J.H., Activation of GABA(A) receptors containing the alpha4 subunit by GABA and pentobarbital. J. Physiol. 556:Pt. 2 (2004), 387–399.
25. [25] Karim, N., et al. Low nanomolar GABA effects at extrasynaptic alpha4beta1/beta3delta GABA(A) receptor subtypes indicate a different binding mode for GABA at these receptors. Biochem. Pharmacol. 84:4 (2012), 549–557.
26. [26] Meera, P., Wallner, M., Otis, T.S., Molecular basis for the high THIP/gaboxadol sensitivity of extrasynaptic GABA(A) receptors. J. Neurophysiol. 106:4 (2011), 2057–2064.
27. [27] Harpsoe, K., et al. Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptors. J. Neurosci. 31:30 (2011), 10759–10766.
28. [28] Hartiadi, L.Y., et al. High and low GABA sensitiv beta2 delta GABA receptors are expressed in Xenopus laevis oocytes with divergent stoichiometries. Biochem. Pharmacol. 103 (2016), 98–108.
29. [29] Keramidas, A., Harrison, N.L., Agonist-dependent single channel current and gating in alpha4beta2delta and alpha1beta2gamma2S GABAA receptors. J. Gen. Physiol. 131:2 (2008), 163–181.
30. [30] Feng, H.J., et al. Etomidate produces similar allosteric modulation in alpha1beta3delta and alpha1beta3gamma2L GABA(A) receptors. Br. J. Pharmacol. 171:3 (2014), 789–798.
31. [31] Abramian, A.M., et al. Protein kinase C phosphorylation regulates membrane insertion of GABAA receptor subtypes that mediate tonic inhibition. J. Biol. Chem. 285:53 (2010), 41795–41805.
32. [32] Kuver, A., Shen, H., Smith, S.S., Regulation of the surface expression of alpha4beta2delta GABAA receptors by high efficacy states. Brain Res. 1463 (2012), 1–20.
33. [33] Belelli, D., et al. The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors. Neuropharmacology 43:4 (2002), 651–661.
34. [34] Olsen, R.W., Allosteric ligands and their binding sites define gamma-aminobutyric acid (GABA) type a receptor subtypes. Adv. Pharmacol. 73 (2015), 167–202.
35. [35] Hanchar, H.J., et al. Ethanol potently and competitively inhibits binding of the alcohol antagonist Ro15-4513 to alpha4/6beta3 delta GABAA receptors. Proc. Natl. Acad. Sci. U. S. A. 103:22 (2006), 8546–8551.
36. [36] de Lucas, A.G., et al. GABAA alpha5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085. Biochem. Pharmacol. 93:3 (2015), 370–379.
37. [37] Stell, B.M., et al. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors. Proc. Natl. Acad. Sci. U. S. A. 100:24 (2003), 14439–14444.